Study record

MOTS-C levels ın ındividuals with and without obesity and ıts association with ınflammation, insulin resistance and endothelial dysfunction

Ozkaya DY, Haymana C, Demirci I et al. · Arch Endocrinol Metab · 2025

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured serum MOTS-c in adults with and without obesity and found no significant difference between the groups. Reported a positive correlation between serum MOTS-c and HOMA-IR but no correlation with high-sensitivity C-reactive protein or asymmetric dimethylarginine, and found in multiple regression that MOTS-c was lower with older age and higher with greater insulin resistance in these participants.

Limitations

Small single-centre cross-sectional sample with unequal groups and no longitudinal data; broad exclusions limit generalisability, endothelial function was assessed only by a single circulating marker, and the null primary comparison may be underpowered.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedAdults with obesity and adults with normal body mass index, sampled after an overnight fast
Populationadults with obesity and adults with normal body mass index, excluding smokers, pregnancy and type 2 diabetes
DesignCross-sectional comparative study
Sample size as reported85 individuals (48 with BMI >= 30, 37 with BMI 18.5-24.9)
Control group37 individuals with normal body mass index
Route (data field only)Not reported
Endpoints measuredserum MOTS-c; HOMA-IR; serum insulin; high-sensitivity C-reactive protein; asymmetric dimethylarginine
Pathways measuredInsulin & glucose handling · Inflammation
Research areasMetabolic · Cardiovascular
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.